$BEAT News

Maxim Group Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2

HeartBeam Wins U.S. Patent Expanding ECG Device With Acoustic Sensing, Impedance Features For Heart Disease Monitoring

HeartBeam Announces Reorganization To Prioritize Global Market Reach And Capital Efficiency While Accelerating Execution; To License Its 3D ECG Signal Technology To Established Partners

HeartBeam (BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients

HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know

HeartBeam (BEAT) Aims to Close Critical Gap in Early Cardiac Detection

HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5

Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5

HeartBeam (BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam, Inc. Q1 2026 Earnings Call Summary

HeartBeam Inc (BEAT) Q1 2026 Earnings Call Highlights: Strategic Partnerships and Financial ...

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Reports First Quarter 2026 Results

HeartBeam, Inc. 2026 Q1 - Results - Earnings Call Presentation

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Q1 EPS $(0.12) Beats $(0.14) Estimate

HeartBeam (BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic